hemodynamics: essentials for future tavr and mitral valve disease · 2020-01-31 · hemodynamics:...
TRANSCRIPT
![Page 1: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/1.jpg)
Hemodynamics: essentials for future
TAVR and mitral valve disease
Morton J. Kern, MD
Professor of Medicine Chief of Cardiology
Associate Chief Cardiology University California Irvine
Orange, California
![Page 2: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/2.jpg)
Disclosure:
Morton J. Kern, MD
Within the past 12 months, the presenter or their
spouse/partner have had a financial interest/arrangement
or affiliation with the organization listed below.
Company Name Relationship
St. Jude Medical Inc. Speakers’ Bureau
Volcano Therapeutics Speakers’ Bureau
Merrit Medical Inc. Consultant
Opsens Consultant
![Page 3: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/3.jpg)
Etiology of Aortic Stenosis From the Euro Heart Survey
Goldbarg, S. H. et al. J Am Coll Cardiol 2007;50:1205-1213
![Page 4: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/4.jpg)
J Am Coll Cardiol. 2012;60(3):169-180.
Pathophysiology of AS
![Page 5: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/5.jpg)
Tri/MV valves open
Pa/Ao valves
are closed
Pa/Ao
valves open
Tri/MV valves close
Pa/Ao
valves close
Tri/MV valves open systole
=Valve action
![Page 6: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/6.jpg)
Mechanism of AS: LV-Ao Gradient
Consequences of LV-Ao
Gradient:
1. late peaking Systolic
murmur
2. Single A2
3. Slow pulse upstroke
![Page 7: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/7.jpg)
BAMC Case #3117:
Patient: 61 yo male
Dx: 3V CAD
filter: 50 Hz/ sample 250 Hz Pre Contrast
Normal LV and Aortic Pressure Fluid-filled system
micromanometer transducers Fluid filled, FA sheath
![Page 8: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/8.jpg)
P-P grad Mean Grad
Peak instantaneous vs P-P
Unshifted=larger Grad
LV
Fusberg and Feldman T, Cath and CV Int 53:553;2001
Hemodynamic Technique
![Page 9: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/9.jpg)
Techniques for Aortic Valve
Gradient Measurement
• Single Catheter LV-Ao pullback
• LV and Femoral Sheath
• LV and Long aortic sheath
• Bilateral femoral access
• Double-lumen pigtail catheter
• Transeptal LV access with ascending Ao
• Pressure Guidewire with ascending Ao
• Multi-transducer micromanometer catheters
Fusberg and Feldman T, Cath and CV Int 53:553;2001
![Page 10: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/10.jpg)
Calculating Aortic Valve Area
• AVA: Gorlin equation
• AVA: Hakke formula (“poor man’s Gorlin”)
– Assumes HR*SEP*44.3 = 1000 in most patients
– Valid for HR ~65-100
AVA = cardiac output (L/min)/√Peak-Peak Pressures
![Page 11: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/11.jpg)
Grading Severity of Aortic Stenosis
AVA AVA Index Aortic Stenosis (cm2) (cm2/m2) Mild >1.5 >0.9 Moderate 1.1-1.5 >0.6-0.9 Severe <0.8-1.0 <0.4-0.6
![Page 12: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/12.jpg)
![Page 13: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/13.jpg)
![Page 14: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/14.jpg)
Hemodynamic Differentiation of LVOT Obstruction
AS HOCM
3 Differentiating features a. Aortic upstroke b. Pulse pressure c. Contour –spike/dome
![Page 15: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/15.jpg)
Low Gradient, Low EF AS?
LVEF 25%
P-P gradient 30mmHg
CO = 3.2l/m Fick
AVA = 0.7cm2
![Page 16: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/16.jpg)
Base 10 Dob+Pace 80 20 Dob + Pace 95
Dobutamine challenge for LG AS
P-P = 50mmHg CO = 4.2l/m
AVA = 0.6cm2
![Page 17: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/17.jpg)
Grayburn, P. A. Circulation 2006;113:604-606
What should you do with Symptomatic AS patient, low gradient, low flow? The Dobutamine Challenge
AVA = 0.7cm2
AVA = 1.0cm2
AVA = 1.5cm2
Fixed area
![Page 18: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/18.jpg)
Chiam, P. T.L. et al. J Am Coll Cardiol Intv 2008;1:341-350
Edwards-Sapien PHV CoreValve PHV
![Page 19: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/19.jpg)
![Page 20: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/20.jpg)
![Page 21: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/21.jpg)
Pre- Post 26mm Sapien Edwards
Anachrotic shoulder, dichrotic notch
Diastolic dysfunction? Delayed upslope
![Page 22: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/22.jpg)
AS+AI
![Page 23: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/23.jpg)
![Page 24: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/24.jpg)
Normal LA and LV
diastolic pressures LA-LV Diastolic Gradient
![Page 25: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/25.jpg)
PCW does not always equal LA
![Page 26: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/26.jpg)
Hemodynamics and Doppler Echo findings before MVBP
![Page 27: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/27.jpg)
![Page 28: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/28.jpg)
Hemodynamic and Doppler Echo findings after MVBP
![Page 29: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/29.jpg)
![Page 30: Hemodynamics: essentials for future TAVR and mitral valve disease · 2020-01-31 · Hemodynamics: essentials for future TAVR and mitral valve disease Morton J. Kern, MD Professor](https://reader034.vdocuments.us/reader034/viewer/2022042912/5f463990b3bb6d3dd605239b/html5/thumbnails/30.jpg)
Hemodynamics for Structrual Heart Disease
Low Gradient AS
Complications of AVP – AI
AS vs. HOCM
Mitral Regurgitation after MVP for MS
Diastolic CHF – constrictive v Restrictive
Tamponade
For your own review consider Intracardiac Shunts